Uncovering mechanisms underlying complement-mediated cancer immune evasion

Affiliations

¹ Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, The Mount Sinai Hospital, New York, NY, USA; Department of Pediatrics, The Mount Sinai Hospital, New York, NY, USA. Electronic address: patrick.oconnell@mountsinai.org.

Patrick O'Connell. Mol Ther. 2024.

. 2024 Feb 7;32(2):277-278.

doi: 10.1016/j.ymthe.2024.01.012. Epub 2024 Jan 20.

¹ Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, The Mount Sinai Hospital, New York, NY, USA; Department of Pediatrics, The Mount Sinai Hospital, New York, NY, USA. Electronic address: patrick.oconnell@mountsinai.org.

No abstract available

Conflict of interest statement

Declaration of interests The author declares no competing interests.

1. Luan X., Lei T., Fang J., Liu X., Fu H., Li Y., Chu W., Jiang P., Tong C., Qi H., Fu Y. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8(+) T cell activity. Mol. Ther. 2023 doi: 10.1016/j.ymthe.2023.12.010. - DOI - PubMed
1. Horiuchi T., Tsukamoto H. Complement-targeted therapy: development of C5- and C5a-targeted inhibition. Inflamm. Regen. 2016;36:11. - PMC - PubMed
1. Gu J., Ding J.Y., Lu C.L., Lin Z.W., Chu Y.W., Zhao G.Y., Guo J., Ge D. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Lung Cancer. 2013;81:259–265. - PubMed
1. Zhang C., Cao K., Yang M., Wang Y., He M., Lu J., Huang Y., Zhang G., Liu H. C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer. Oncoimmunology. 2023;12 - PMC - PubMed
1. Dunkelberger J., Zhou L., Miwa T., Song W.C. C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity. J. Immunol. 2012;188:4032–4042. - PMC - PubMed